BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11137357)

  • 1. TEOAE monitoring of Cisplatin induced ototoxicity in guinea pigs: the protective effect of vitamin B treatment.
    Güneri EA; Serbetçioğlu B; Ikiz AO; Güneri A; Ceryan K
    Auris Nasus Larynx; 2001 Jan; 28(1):9-14. PubMed ID: 11137357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Sensorineural Hearing Loss Using Various Transient-Evoked Otoacoustic Emission Stimulus Conditions.
    Putterman DB; Keefe DH; Hunter LL; Garinis AC; Fitzpatrick DF; McMillan GP; Feeney MP
    Ear Hear; 2017; 38(4):507-520. PubMed ID: 28437273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin ototoxicity and otoprotection with sodium salicylate.
    Hyppolito MA; de Oliveira JA; Rossato M
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):798-803. PubMed ID: 16758221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinically Viable Medial Olivocochlear Reflex Assay Using Transient-Evoked Otoacoustic Emissions.
    Lapsley Miller JA; Reed CM; Marshall L; Perez ZD; Villabona T
    Ear Hear; 2024 Jan-Feb 01; 45(1):115-129. PubMed ID: 37475147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
    Sockalingam R; Freeman S; Cherny TL; Sohmer H
    Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the medial olivocochlear efferent system in children. pure tone 1.0 kHz and 2.0 kHz suppressive effects on transient evoked otoacoustic emission.
    Morawski K; Namyslowski G; Kossowska I; Lisowska G; Urbaniec P
    Scand Audiol Suppl; 2001; (52):112-5. PubMed ID: 11318438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
    Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
    Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient evoked otoacoustic emissions in patients with normal hearing and in patients with hearing loss.
    Hussain DM; Gorga MP; Neely ST; Keefe DH; Peters J
    Ear Hear; 1998 Dec; 19(6):434-49. PubMed ID: 9867292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity.
    Fetoni AR; Sergi B; Ferraresi A; Paludetti G; Troiani D
    Acta Otolaryngol; 2004 May; 124(4):421-6. PubMed ID: 15224867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEOAE-based estimation of the auditory threshold in the mid-octave frequencies.
    Hatzopoulos S; Martini A; Stephens SD
    Br J Audiol; 1999 Dec; 33(6):415-22. PubMed ID: 10656602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the protective effect of α-lipoic acid on cisplatin ototoxicity using distortion-product otoacoustic emission measurements: an experimental animal study.
    Ozkul Y; Songu M; Basoglu MS; Ozturkcan S; Katilmis H
    J Craniofac Surg; 2014 Jul; 25(4):1515-8. PubMed ID: 24905944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of auditory brain-stem responses, distortion product otoacoustic emissions, hair cell loss, and forward masked tuning curves in the waltzing guinea pig.
    Canlon B; Marklund K; Borg E
    J Acoust Soc Am; 1993 Dec; 94(6):3232-43. PubMed ID: 8300958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes to low-frequency components of the TEOAE following acoustic trauma to the base of the cochlea.
    Withnell RH; Yates GK; Kirk DL
    Hear Res; 2000 Jan; 139(1-2):1-12. PubMed ID: 10601708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal curcumin and vitamin E combination for the treatment of cisplatin-induced ototoxicity in rats.
    Soyalıç H; Gevrek F; Koç S; Avcu M; Metin M; Aladağ İ
    Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():173-8. PubMed ID: 27619052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in transient-evoked otoacoustic emission levels with negative tympanometric peak pressure in infants and toddlers.
    Prieve BA; Calandruccio L; Fitzgerald T; Mazevski A; Georgantas LM
    Ear Hear; 2008 Aug; 29(4):533-42. PubMed ID: 18469719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of various durations of noise exposure on auditory brainstem response, distortion product otoacoustic emissions and transient evoked otoacoustic emissions in rats.
    Fraenkel R; Freeman S; Sohmer H
    Audiol Neurootol; 2001; 6(1):40-9. PubMed ID: 11173774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.